• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON CARIBE LTD. BD BACTEC¿ LYTIC/10 ANAEROBIC/F CULTURE VIALS (PLASTIC); SYSTEM, BLOOD CULTURING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON CARIBE LTD. BD BACTEC¿ LYTIC/10 ANAEROBIC/F CULTURE VIALS (PLASTIC); SYSTEM, BLOOD CULTURING Back to Search Results
Model Number 442021
Device Problem Device Markings/Labelling Problem (2911)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/04/2022
Event Type  malfunction  
Event Description
It was reported by the customer that bd bactec¿ lytic/10 anaerobic/f culture vials (plastic) had no label or missing label information (all packaging levels).There was one occurrence in this event with no patient impact.The following information was provided by the customer: "the nurse followed the doctor's instructions to carry out blood culture + drug sensitivity blood draw for the patient, found that the bottle label part of the anaerobic microbial culture bottle was missing, the nurse believed that the reagent bottle itself was not damaged, and within the validity period, the product was used to continue to complete the blood collection, after the specimen was sent for examination, because the label was missing, the laboratory department could not detect, the consumables were discarded, that is, the material supply management department was reported to the material supply management department, and the material supply management department was investigated, and the procurement office notified the supplier to the department to view and process.".
 
Manufacturer Narrative
Initial reporter phone number: (b)(6).A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Manufacturer Narrative
H.6 investigation summary: satisfactory results were obtained from retention samples when visually inspected for reported defect (no vial label).Batch history record review did not identify any evidence for which the customer submitted the complaint.A complaint history review was conducted and only the current complaint was found relating to the incident lot number and the ¿as reported¿ defect code.Complaint is unconfirmed based on retention samples and batch history record review.Product insert warnings and precautions sections states that prior to use, each vial should be examined for evidence of contamination such as cloudiness, bulging or depresses septum, or leakage.Vials showing evidence of contamination should not be used.Also prior to use, the user should examine the vial for evidence of damage or deterioration.Vials displaying turbidity, contamination, or discoloration (darkening) should not be used.No corrective actions were required.A cross functional team continually monitors all product complaints for trends and determines if any additional actions are necessary beyond the current investigational process.
 
Event Description
It was reported by the customer that bd bactec¿ lytic/10 anaerobic/f culture vials (plastic) had no label or missing label information (all packaging levels).There was one occurrence in this event with no patient impact.The following information was provided by the customer: "the nurse followed the doctor's instructions to carry out blood culture + drug sensitivity blood draw for the patient, found that the bottle label part of the anaerobic microbial culture bottle was missing, the nurse believed that the reagent bottle itself was not damaged, and within the validity period, the product was used to continue to complete the blood collection, after the specimen was sent for examination, because the label was missing, the laboratory department could not detect, the consumables were discarded, that is, the material supply management department was reported to the material supply management department, and the material supply management department was investigated, and the procurement office notified the supplier to the department to view and process.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD BACTEC¿ LYTIC/10 ANAEROBIC/F CULTURE VIALS (PLASTIC)
Type of Device
SYSTEM, BLOOD CULTURING
Manufacturer (Section D)
BECTON DICKINSON CARIBE LTD.
vicks drive
lot no. 6
cayey PR
Manufacturer (Section G)
BECTON DICKINSON CARIBE LTD.
vicks drive
lot no. 6
cayey PR
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key15456960
MDR Text Key306322393
Report Number3008352382-2022-00004
Device Sequence Number1
Product Code MDB
UDI-Device Identifier00382904420215
UDI-Public(01)00382904420215
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K123903
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 11/08/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date12/31/2022
Device Model Number442021
Device Catalogue Number442021
Device Lot Number2041433
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/14/2022
Initial Date FDA Received09/20/2022
Supplement Dates Manufacturer Received11/08/2022
Supplement Dates FDA Received11/22/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/10/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-